Clinic
Curtis V. Cooper Primary Health Care INC.
Curtis V. Cooper Primary Health Care INC. was paid $16.53M by Medicaid between Jan 2018 and Dec 2024, across 217 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoCURTIS V. COOPER PRIMARY HEALTH CARE INC.
SAVANNAH, GA 31405
SAVANNAH, GA 31405
33aNPI1841683067assigned 03/12/2015
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$16.53M
24GClaims1,415,084
24DCodes billed217
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Georgia
Rank by total paid#2 of 13
Median peer was paid$30K
This provider vs. median544×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 155,388 | $1.23M | |
| 2019 | 221,275 | $1.33M | |
| 2020 | 225,917 | $2.13M | |
| 2021 | 245,225 | $3.17M | |
| 2022 | 224,989 | $3.32M | |
| 2023 | 176,681 | $2.77M | |
| 2024incomplete | 165,609 | $2.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 63,142 | 45,244 | $7.65M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14% | 19,933 | 16,385 | $2.27M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 12,378 | 9,913 | $1.40M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 4,829 | 4,474 | $566K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 5,593 | 4,184 | $523K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.2% | 4,428 | 4,056 | $521K |
| D0999 | Unspecified diagnostic procedure, by report | 3.0% | 4,114 | 3,741 | $504K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 4,013 | 3,246 | $437K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.5% | 4,157 | 2,678 | $420K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.4% | 3,478 | 3,126 | $403K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.9% | 2,880 | 2,293 | $311K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 10,885 | 9,605 | $221K |
205 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,374 | $128K |
| D0330 | Panoramic radiographic image | <1% | 2,240 | $101K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,216 | $100K |
| 99381 | <1% | 928 | $83K | |
| D1120 | Dental cleaning, child | <1% | 1,528 | $72K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 801 | $67K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,053 | $46K |
| 99383 | <1% | 373 | $43K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 861 | $42K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 345 | $40K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,972 | $35K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 311 | $32K |
| 99384 | <1% | 235 | $28K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,057 | $27K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,455 | $24K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,162 | $23K |
| D1110 | Prophylaxis - adult | <1% | 655 | $22K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 30 | $19K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 380 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,339 | $18K |
| 99382 | <1% | 165 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,568 | $17K |
| 81003 | <1% | 46,493 | $15K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 156 | $14K |
| 99173 | <1% | 4,334 | $13K | |
| 59514 | <1% | 18 | $13K | |
| 2000F | <1% | 81,929 | $10K | |
| 3028F | <1% | 108,316 | $9K | |
| 2001F | <1% | 95,785 | $9K | |
| 2010F | <1% | 110,468 | $9K | |
| 3008F | <1% | 100,362 | $9K | |
| 81025 | <1% | 20,014 | $9K | |
| 1220F | <1% | 52,221 | $8K | |
| 92551 | <1% | 2,695 | $8K | |
| 90837 | Psychotherapy session, about an hour | <1% | 101 | $7K |
| 99429 | <1% | 537 | $7K | |
| 1036F | <1% | 37,461 | $7K | |
| 3074F | <1% | 53,146 | $6K | |
| 1160F | <1% | 43,900 | $6K | |
| 0001A | <1% | 196 | $6K | |
| 90715 | <1% | 1,773 | $6K | |
| 99385 | <1% | 111 | $6K | |
| 3078F | <1% | 55,633 | $5K | |
| 3016F | <1% | 23,842 | $5K | |
| 0002A | <1% | 156 | $5K | |
| 85018 | <1% | 11,103 | $5K | |
| 0012A | <1% | 168 | $5K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,414 | $4K |
| 1126F | <1% | 45,414 | $4K | |
| D1351 | Sealant - per tooth | <1% | 451 | $4K |
| 0011A | <1% | 196 | $3K | |
| 1159F | <1% | 31,979 | $3K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 23 | $3K |
| D0140 | Limited oral evaluation - problem focused | <1% | 262 | $3K |
| 3725F | <1% | 21,239 | $3K | |
| 3351F | <1% | 17,947 | $3K | |
| 3079F | <1% | 15,796 | $3K | |
| 96161 | <1% | 1,577 | $2K | |
| 1000F | <1% | 21,811 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 22 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 710 | $2K |
| 90686 | <1% | 1,579 | $2K | |
| 91300 | <1% | 193 | $2K | |
| 99401 | <1% | 1,504 | $2K | |
| 3292F | <1% | 5,703 | $2K | |
| 3512F | <1% | 7,601 | $1K | |
| 3037F | <1% | 17,408 | $1K | |
| D0272 | Bitewings - two radiographic images | <1% | 1,251 | $1K |
| 3075F | <1% | 8,518 | $1K | |
| 90651 | <1% | 2,406 | $1K | |
| 3511F | <1% | 4,837 | $1K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 35 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 379 | $1K |
| 3015F | <1% | 2,608 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 315 | $1K |
| 82962 | <1% | 8,370 | $974.21 | |
| 3754F | <1% | 9,747 | $967.07 | |
| 3280F | <1% | 3,713 | $950.30 | |
| 0503F | <1% | 417 | $935.09 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,783 | $844.09 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,777 | $838.50 |
| 90662 | <1% | 1,196 | $809.23 | |
| 54150 | <1% | 15 | $774.10 | |
| 3077F | <1% | 9,514 | $744.43 | |
| 90670 | <1% | 3,318 | $738.63 | |
| 3080F | <1% | 7,729 | $725.49 | |
| D0120 | Dental checkup, returning patient | <1% | 227 | $695.60 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,330 | $689.43 |
| 3281F | <1% | 2,960 | $665.21 | |
| 1034F | <1% | 6,420 | $648.44 | |
| 3279F | <1% | 2,700 | $642.85 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 185 | $612.40 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 147 | $610.59 |
| 0071A | <1% | 16 | $600.05 | |
| 86592 | <1% | 1,554 | $568.15 | |
| D0274 | Bitewings - four radiographic images | <1% | 65 | $567.34 |
| 3514F | <1% | 3,451 | $559.00 | |
| 0031A | <1% | 40 | $520.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 4,301 | $470.88 |
| 86803 | <1% | 883 | $448.16 | |
| 90688 | <1% | 1,355 | $447.28 | |
| 1125F | <1% | 10,455 | $444.35 | |
| 90661 | <1% | 137 | $424.40 | |
| 3044F | <1% | 1,771 | $399.46 | |
| 4293F | <1% | 1,890 | $391.30 | |
| 91301 | <1% | 87 | $361.36 | |
| 83655 | <1% | 294 | $359.90 | |
| 1124F | <1% | 3,636 | $346.58 | |
| 82950 | <1% | 483 | $319.60 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 761 | $305.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 28 | $274.12 |
| 59025 | Fetal non-stress test | <1% | 69 | $271.10 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,148 | $241.64 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 146 | $237.95 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 52 | $235.40 |
| 90620 | <1% | 1,068 | $234.84 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 181 | $216.10 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,345 | $184.47 |
| 3011F | <1% | 3,118 | $173.29 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,434 | $162.11 |
| 3046F | <1% | 282 | $160.03 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,463 | $156.52 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,937 | $156.52 |
| 92552 | <1% | 30 | $150.51 | |
| 4010F | <1% | 813 | $150.01 | |
| 0500F | <1% | 13 | $150.00 | |
| 80061 | Lipid panel | <1% | 1,787 | $139.75 |
| 90687 | <1% | 190 | $126.26 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 227 | $126.26 |
| 1158F | <1% | 572 | $106.21 | |
| 4013F | <1% | 4,297 | $78.26 | |
| 99001 | <1% | 222 | $33.54 | |
| 1006F | <1% | 165 | $27.95 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 179 | $26.19 |
| 1031F | <1% | 131 | $22.36 | |
| 0001F | <1% | 850 | $16.77 | |
| 3330F | <1% | 160 | $16.77 | |
| 1033F | <1% | 17 | $11.18 | |
| 90734 | <1% | 1,182 | $11.18 | |
| 3049F | <1% | 192 | $11.18 | |
| G0467 | Community health center visit, returning patient | <1% | 8,950 | $11.18 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 145 | $9.99 |
| 90633 | <1% | 2,229 | $5.59 | |
| 3048F | <1% | 388 | $5.59 | |
| 1038F | <1% | 27 | $5.59 | |
| 87210 | <1% | 305 | $4.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 18 | $0.33 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 4,858 | $0.04 |
| 3050F | <1% | 99 | $0.01 | |
| 90707 | 0% | 185 | $0.00 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 10,242 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 36 | $0.00 |
| 84439 | 0% | 253 | $0.00 | |
| 4120F | 0% | 178 | $0.00 | |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 5,085 | $0.00 |
| G4067 | 0% | 71 | $0.00 | |
| 90710 | 0% | 1,375 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 2,840 | $0.00 |
| 86787 | 0% | 40 | $0.00 | |
| 0502F | 0% | 507 | $0.00 | |
| 4025F | 0% | 1,416 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 366 | $0.00 |
| D0190 | 0% | 623 | $0.00 | |
| 90648 | 0% | 186 | $0.00 | |
| 1039F | 0% | 143 | $0.00 | |
| 90681 | 0% | 416 | $0.00 | |
| 90655 | 0% | 129 | $0.00 | |
| 90713 | 0% | 148 | $0.00 | |
| 90785 | 0% | 195 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 22 | $0.00 |
| 4040F | 0% | 612 | $0.00 | |
| 90700 | 0% | 553 | $0.00 | |
| 1007F | 0% | 206 | $0.00 | |
| 1032F | 0% | 732 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 68 | $0.00 |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 0% | 13 | $0.00 |
| 82274 | 0% | 39 | $0.00 | |
| 87806 | 0% | 69 | $0.00 | |
| G0466 | Community health center visit, new patient | 0% | 21 | $0.00 |
| 3352F | 0% | 192 | $0.00 | |
| 90696 | 0% | 710 | $0.00 | |
| 90723 | 0% | 2,595 | $0.00 | |
| 4037F | 0% | 911 | $0.00 | |
| 90647 | 0% | 2,209 | $0.00 | |
| 90677 | 0% | 999 | $0.00 | |
| 90680 | 0% | 1,785 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,682 | $0.00 |
| 90697 | 0% | 647 | $0.00 | |
| 90716 | 0% | 256 | $0.00 | |
| 4008F | 0% | 489 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 278 | $0.00 |
| 90619 | 0% | 735 | $0.00 | |
| 4016F | 0% | 384 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 83 | $0.00 |
| 90744 | 0% | 52 | $0.00 | |
| 80055 | 0% | 15 | $0.00 | |
| 87430 | 0% | 13 | $0.00 | |
| 85027 | 0% | 27 | $0.00 | |
| 84153 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 90660 | 0% | 151 | $0.00 | |
| 1111F | 0% | 13 | $0.00 | |
| 91307 | 0% | 13 | $0.00 | |
| 90656 | 0% | 16 | $0.00 | |
| D4355 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANIELS, EARLENE (CHIEF ADMINISTRATIVE OFFICER)